Targeted therapies developed to reduce lung fibrosis

hi INDiA

Washington [US], November 11 (ANI): A new treatment option for lung fibrosis is being developed by Purdue University scientists. Lung fibrosis has been a concern for COVID-19 patients.People with idiopathic pulmonary fibrosis (IPF) have a life expectancy of less than five years. Fibrotic diseases cause organ failure that leads to about 45% of all deaths […]

The post Targeted therapies developed to reduce lung fibrosis appeared first on hi INDiA.
http://dlvr.it/RlRCbd